Farmed Salmon Genetic Welfare: Rapid Growth and Health Trade-offs

Atlantic salmon bred for rapid growth in aquaculture experience welfare costs analogous to fast-growing broiler chickens, with cardiac and skeletal problems linked to accelerated growth genetics.

Key Facts

Farmed Atlantic salmon grow up to five times faster than their wild counterparts due to selective breeding
Heart and skeletal muscle inflammation is significantly more common in fast-growing farmed salmon
Cataracts affect up to 80% of some farmed salmon cohorts and are linked to dietary and genetic factors
Spinal deformities are more common in farmed than wild salmon due to growth rate and nutrition
Cardiomyopathy syndrome causes heart muscle failure and is a significant mortality cause in farms
Slower-growing genetic lines show fewer health problems but reduced economic efficiency

Welfare Considerations

Farmed salmon genetics have created welfare problems analogous to those seen in fast-growing broiler chickens: bodies growing faster than hearts, skeletons, and immune systems can support. Cataracts, heart disease, and skeletal deformities are not random misfortunes — they are predictable consequences of extreme growth rate selection. The solution, as in poultry, involves genetic reform toward slower-growing, more robust strains. The welfare and production costs of health problems in fast-growing fish are increasingly recognized by the industry, creating economic as well as ethical incentives for genetic improvement.

What You Can Do

Choose salmon from producers who disclose welfare outcomes and growth rate information
Support research into welfare-compatible salmon genetics that prioritize health alongside growth
Advocate for welfare standards that set maximum growth rate limits for farmed salmon
Reduce salmon consumption or shift to species with fewer systemic welfare problems in aquaculture